DK3290436T3 - Phenylalanin-fri protein til behandlingen af pku - Google Patents

Phenylalanin-fri protein til behandlingen af pku Download PDF

Info

Publication number
DK3290436T3
DK3290436T3 DK16186895.5T DK16186895T DK3290436T3 DK 3290436 T3 DK3290436 T3 DK 3290436T3 DK 16186895 T DK16186895 T DK 16186895T DK 3290436 T3 DK3290436 T3 DK 3290436T3
Authority
DK
Denmark
Prior art keywords
pku
phenylalanine
treatment
free protein
protein
Prior art date
Application number
DK16186895.5T
Other languages
English (en)
Inventor
Bernhard Hoffmann
Yvonne Mücke
Stefan Rasche
Natalia Jablonka
Stefan Schillberg
Original Assignee
Metax Inst Fuer Diaetetik Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Metax Inst Fuer Diaetetik Gmbh filed Critical Metax Inst Fuer Diaetetik Gmbh
Application granted granted Critical
Publication of DK3290436T3 publication Critical patent/DK3290436T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/32Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/195Proteins from microorganisms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00Food ingredients
    • A23V2250/54Proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/20Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/21Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Polymers & Plastics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Soy Sauces And Products Related Thereto (AREA)
  • General Preparation And Processing Of Foods (AREA)
DK16186895.5T 2016-09-01 2016-09-01 Phenylalanin-fri protein til behandlingen af pku DK3290436T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP16186895.5A EP3290436B1 (en) 2016-09-01 2016-09-01 Phenylalanine-free protein for the treatment of pku

Publications (1)

Publication Number Publication Date
DK3290436T3 true DK3290436T3 (da) 2019-08-19

Family

ID=56883591

Family Applications (1)

Application Number Title Priority Date Filing Date
DK16186895.5T DK3290436T3 (da) 2016-09-01 2016-09-01 Phenylalanin-fri protein til behandlingen af pku

Country Status (27)

Country Link
US (1) US10640538B2 (da)
EP (1) EP3290436B1 (da)
JP (1) JP6954676B2 (da)
CN (1) CN109661401B (da)
AU (1) AU2017317652B2 (da)
BR (1) BR112019004270A2 (da)
CA (1) CA3033271C (da)
CY (1) CY1121886T1 (da)
DK (1) DK3290436T3 (da)
ES (1) ES2742175T3 (da)
HR (1) HRP20191406T1 (da)
HU (1) HUE044665T2 (da)
IL (1) IL265015B2 (da)
LT (1) LT3290436T (da)
MA (1) MA43352B1 (da)
MD (1) MD3290436T2 (da)
ME (1) ME03510B (da)
MX (1) MX2019002422A (da)
NZ (1) NZ750498A (da)
PL (1) PL3290436T3 (da)
PT (1) PT3290436T (da)
RU (1) RU2764796C2 (da)
SA (1) SA519401175B1 (da)
SI (1) SI3290436T1 (da)
UA (1) UA124630C2 (da)
WO (1) WO2018041920A1 (da)
ZA (1) ZA201901505B (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113214363B (zh) * 2019-09-27 2022-12-06 湖北康肽药业有限公司 一组特殊膳食蛋白质
CN110747218A (zh) * 2019-09-27 2020-02-04 深圳市诺维健生物技术有限责任公司 一种特殊膳食蛋白质的生产方法与应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04126051A (ja) * 1990-09-18 1992-04-27 Snow Brand Milk Prod Co Ltd フェニルケトン尿症患者用栄養調製物
GB9310472D0 (en) 1993-05-20 1993-07-07 Univ Warwick Phenylalanine-free protein and dna coding thereof
GB9314802D0 (en) * 1993-07-16 1993-08-25 Pharmaceutical Proteins Ltd Modified proteins
WO1996017064A1 (en) 1994-12-02 1996-06-06 Indiana University Foundation Phenylalanine free proteins
EP1092769B1 (de) * 1999-10-15 2008-10-29 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Polypeptid-Tag's für den Nachweis und die Aufreinigung von Polypeptiden
DK1339837T3 (da) * 2000-12-07 2008-06-09 Dsm Ip Assets Bv Prolyl-endoprotease fra Aspergillus Niger
US9034402B2 (en) * 2007-04-16 2015-05-19 Solae, Llc Protein hydrolysate compositions having improved sensory characteristics and physical properties
EP2142651B1 (en) 2007-04-27 2013-05-22 Pfenex Inc. Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
WO2010124180A1 (en) * 2009-04-23 2010-10-28 Phasebio Pharmaceuticals, Inc. Phenylalanine hydroxylase fusion protein and methods for treating phenylketonuria
WO2013133691A1 (en) * 2012-03-09 2013-09-12 N.V. Nutricia Liquid nutritional composition comprising free amino acids
US20150126441A1 (en) 2012-03-26 2015-05-07 Pronutria, Inc. Nutritive Fragments and Proteins with Low or No Phenylalanine and Methods
EP2922416A4 (en) 2012-11-20 2016-07-20 Pronutria Inc MANIPULATED SECRETATED PROTEINS AND METHOD
ES2896401T3 (es) 2014-09-22 2022-02-24 Tanea Medical Ab Proteínas recombinantes exentas de Phe para su uso en el tratamiento de la fenilcetonuria

Also Published As

Publication number Publication date
LT3290436T (lt) 2019-10-10
AU2017317652B2 (en) 2020-11-19
JP6954676B2 (ja) 2021-10-27
HUE044665T2 (hu) 2019-11-28
RU2764796C2 (ru) 2022-01-21
JP2019533988A (ja) 2019-11-28
BR112019004270A2 (pt) 2019-06-04
MA43352A (fr) 2018-03-07
IL265015A (da) 2019-04-30
WO2018041920A1 (en) 2018-03-08
CN109661401A (zh) 2019-04-19
UA124630C2 (uk) 2021-10-20
HRP20191406T1 (hr) 2019-11-15
MD3290436T2 (ro) 2019-10-31
US20190202872A1 (en) 2019-07-04
NZ750498A (en) 2023-01-27
RU2019109142A (ru) 2020-10-01
EP3290436B1 (en) 2019-06-05
CA3033271C (en) 2024-04-02
PT3290436T (pt) 2019-08-30
CA3033271A1 (en) 2018-03-08
IL265015B2 (en) 2024-08-01
RU2019109142A3 (da) 2021-01-27
PL3290436T3 (pl) 2020-01-31
SA519401175B1 (ar) 2022-01-08
AU2017317652A1 (en) 2019-02-28
SI3290436T1 (sl) 2019-11-29
EP3290436A1 (en) 2018-03-07
IL265015B1 (en) 2024-04-01
MA43352B1 (fr) 2019-08-30
CN109661401B (zh) 2023-12-19
MX2019002422A (es) 2019-07-04
ZA201901505B (en) 2020-08-26
CY1121886T1 (el) 2020-10-14
ES2742175T3 (es) 2020-02-13
ME03510B (me) 2020-04-20
US10640538B2 (en) 2020-05-05

Similar Documents

Publication Publication Date Title
DK3570844T3 (da) Azolopyrimidin til behandlingen af kræftrelaterede lidelser
DK3173092T3 (da) Rna-holdig sammensætning til behandling af tumorsygdomme
DK3439635T3 (da) Formuleringer til behandling af fast tumor
DK3785717T3 (da) Fremgangsmåder til behandling af coronaviridae-infektioner
DK3331915T3 (da) Immun-checkpoint-inhibitorer til anvendelse til behandling af blodbårne cancere
DK3288581T3 (da) Fremgangsmåde til behandling af cancer
DK3096798T3 (da) Plasmakallikreinbindende proteiner og anvendelser deraf til behandling af hereditært angioødem
DK3556775T3 (da) Anti-lag-3 antistoffer til behandling af hæmatologiske maligniteter
DK3102673T3 (da) Fremgangsmåder og sammensætninger til behandling af beta-talassæmi
DK3390390T3 (da) Bipyrazolylderivater egnede til behandling af autoimmunsygdomme
DK3362066T3 (da) Kombinationsterapi til behandling af maligniteter
DK3609529T3 (da) Rna til behandling af autoimmune sygdomme
DK3481846T3 (da) 11-substituerede 24-hydroxysteroler til anvendelse til behandling af nmda-relaterede tilstande
DK3242947T3 (da) Genterapi og elektroporese til behandling af maligniteter
DK3524255T3 (da) Sammensætning til behandling af acne
DK3730511T3 (da) Proteinoprensning
DK3468604T3 (da) Farmaceutiske kombinationer til behandling af cancer
DK3430143T3 (da) Inhibitorer af SRSF1 til behandlingen af neurodegenerative sygdomme
DK3400072T3 (da) Formuleringer til behandling af blærecancer
DK3522873T3 (da) Sammensætninger og fremgangsmåder til behandlingen af xerostomi
DK3578562T3 (da) L-valinatamidbenzoxaborolderivater til behandling af parasitiske sygdomme
DK3618845T3 (da) Peptider til behandling af diabetes
DK3585808T3 (da) Modificerede serpiner til behandlingen af bradykinin formidlet sygdom
DK3302573T3 (da) Sammensætning til behandlingen af hjernelæsioner
DK3506901T3 (da) Anvendelse af kynurensyre til behandling af muskelatrofi